Valentina Fragliasso

10PUBLICATIONS
38CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Humoural immunology and immunochemistryMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 28, 2025
CD20-Negative Large B-Cell Lymphomas: The Diagnostic Challenge of Tumors with Downregulation of Mature B-Cell Marker Expression.

Magda Zanelli, Maurizio Zizzo, Francesca Sanguedolce

|Jul 02, 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma.

Claudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli

|Jun 27, 2024
Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art.

Magda Zanelli, Valentina Fragliasso, Paola Parente

|Apr 10, 2024
HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression.

Annalisa Tameni, Selene Mallia, Veronica Manicardi

Pageof 2